| Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2 S Satarker, M Nampoothiri Archives of Medical Research 51 (6), 482-491, 2020 | 416 | 2020 |
| JAK-STAT pathway inhibition and their implications in COVID-19 therapy S Satarker, AA Tomb, AR Shaji, A Alosious, M Luvis, M Nampoothiri Postgraduate Medicine, 10.1080/00325481.2020.1855921, 2020 | 144 | 2020 |
| Hydroxychloroquine in COVID-19: potential mechanism of action against SARS-CoV-2 S Satarker, T Ahuja, M Banerjee, VB E, S Dogra, T Agarwal, ... Current pharmacology reports 6, 203-211, 2020 | 101 | 2020 |
| Involvement of the nervous system in COVID-19: The bell should toll in the brain S Satarker, M Nampoothiri Life Sciences 262 (December), 118568 DOI: https://doi.org/10.1016/j.lf, 2020 | 64 | 2020 |
| Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders S Satarker, SL Bojja, PC Gurram, J Mudgal, D Arora, M Nampoothiri Cells 11 (7), 1139, 2022 | 40 | 2022 |
| In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease S Satarker, S Maity, J Mudgal, M Nampoothiri Molecular Diversity, 10.1007/s11030-021-10276-6, 2021 | 14 | 2021 |
| Dopaminergic signaling as a plausible modulator of astrocytic toll-like receptor 4: a crosstalk between neuroinflammation and cognition PC Gurram, S Manandhar, S Satarker, J Mudgal, D Arora, M Nampoothiri CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2023 | 11 | 2023 |
| Astrocytic MicroRNAs and transcription factors in Alzheimer’s disease and therapeutic interventions A Nassar, T Kodi, S Satarker, P Chowdari Gurram, D Upadhya, F Sm, ... Cells 11 (24), 4111, 2022 | 11 | 2022 |
| Zinc as a plausible epigenetic modulator of glioblastoma multiforme V Balaji E, N Kumar, S Satarker, M Nampoothiri European Journal of Pharmacology, 173549, 2020 | 11 | 2020 |
| Dialogue between neuroinflammation and neurodegenerative diseases in COVID-19 B Chowdhury, A Sharma, S Satarker, J Mudgal, N Madhavan Journal of Environmental Pathology, Toxicology and Oncology, 10.1615 …, 2021 | 9 | 2021 |
| Rodent models for dry eye syndrome: Standardization using benzalkonium chloride and scopolamine hydrobromide P Chaudhari, S Satarker, R Thomas, N Theruveethi, V Ghate, ... Life Sciences 317, 121463, 2023 | 6 | 2023 |
| Avanafil mediated dual inhibition of IKKβ and TNFR1 in an experimental paradigm of Alzheimer’s disease: in silico and in vivo approach P Chowdari Gurram, S Satarker, G Kumar, F Begum, C Mehta, U Nayak, ... Journal of Biomolecular Structure and Dynamics 41 (20), 10659-10677, 2023 | 5 | 2023 |
| Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies A Nassar, S Satarker, PC Gurram, D Upadhya, SM Fayaz, M Nampoothiri Molecular Neurobiology 60 (10), 5557-5577, 2023 | 5 | 2023 |
| Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson’s disease and advanced therapeutic strategies A Nassar, T Kodi, S Satarker, PC Gurram, SM Fayaz, M Nampoothiri Gene, 147898, 2023 | 3 | 2023 |
| In-silico lead identification of the pan-mutant IDH1 and IDH2 inhibitors to target glioblastoma V Balaji E, S Satarker, BH Kumar, S Pandey, SR Birangal, UY Nayak, ... Journal of Biomolecular Structure and Dynamics 42 (7), 3764-3789, 2024 | 1 | 2024 |
| Spermidine, an autophagy inducer, as a therapeutic antiaging strategy M Nampoothiri, KK Kolathur, R Sankhe, S Satarker Emerging anti-aging strategies, 135-153, 2023 | 1 | 2023 |
| Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s … JMMN Prasada Chowdari Gurram, Sairaj Satarker, Ajmal Nassar Chemical Papers, https://doi.org/10.1007/s11696-022-02598, 2022 | 1* | 2022 |
| In silico screening of existing FDA approved drugs for spermine synthase inhibition as a therapeutic approach in Alzheimer’s disease J Wilson, M Nampoothiri, S Sairaj DRUG DEVELOPMENT 17 (S9), e058496, 2021 | 1 | 2021 |
| Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems A Greeny, A Nair, P Sadanandan, S Satarker, AC Famurewa, ... Biology 13 (3), 157, 2024 | | 2024 |
| Deciphering the molecular mechanism of REST regulation through DEGs and TFs in Alzheimer’s disease A Nassar, M Nampoothiri, PC Gurram, S Satarker, D Upadhya, ... Journal of Applied Pharmaceutical Science 14 (2), 083-092, 2024 | | 2024 |
Dr. Madhavan NampoothiriManipal College of Pharmaceutical Sciences在 manipal.edu 的电子邮件经过验证
